PHARMACOLOGY AND TOXICOLOGY OF A DEFIBRINATING SUBSTANCE FROM MALAYAN PIT VIPER VENOM
- 9 March 1968
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 291 (7541) , 486-489
- https://doi.org/10.1016/s0140-6736(68)91464-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- THERAPEUTIC DEFIBRINATION IN THE TREATMENT OF THROMBOTIC DISEASEThe Lancet, 1968
- Actions of Thrombin and Other Coagulant and Proteolytic Enzymes on Blood PlateletsNature, 1967
- DISPOSITION OF 3H‐EPSILON AMINO CAPROIC ACID AND ITS INTERACTION WITH ADRENERGIC NEURONESBritish Journal of Pharmacology and Chemotherapy, 1967
- The Isolation and Properties of the Thrombin‐like Activity from Ancistrodon rhodostoma VenomBritish Journal of Haematology, 1967
- In vivo effects of Agkistrodon rhodostoma venom: studies with fibrinogen-131I.Journal of Clinical Investigation, 1966
- A Study of the Coagulant Properties of Malayan Pit-Viper VenomBritish Journal of Haematology, 1965
- FIBRINOLYSIS AND THE DEFIBRINATION SYNDROME OF MALAYAN VIPER BITEThe Lancet, 1964
- PROLONGED COAGULATION DEFECT (DEFIBRINATION SYNDROME) IN MALAYAN VIPER BITEThe Lancet, 1963
- RETICULOENDOTHELIAL CLEARANCE OF CIRCULATING FIBRIN IN THE PATHOGENESIS OF THE GENERALIZED SHWARTZMAN REACTIONThe Journal of Experimental Medicine, 1962
- STUDIES ON THE GENERALIZED SHWARTZMAN REACTIONThe Journal of Experimental Medicine, 1952